ProQR Therapeutics N.V. Profit Loss Attributable To Noncontrolling Interests
ProQR Therapeutics N.V. (PRQR) reported Profit Loss Attributable To Noncontrolling Interests of EUR 384.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:ProfitLossAttributableToNoncontrollingInterests · last filed 2026-03-12
- ProQR Therapeutics N.V. profit loss attributable to noncontrolling interests for the quarter ending 2023-12-31 was 0.00 EUR.
- ProQR Therapeutics N.V. profit loss attributable to noncontrolling interests for the quarter ending 2023-09-30 was 290.00K EUR, a 1971.43% increase year-over-year.
- ProQR Therapeutics N.V. profit loss attributable to noncontrolling interests for the quarter ending 2023-06-30 was 16.00K EUR, a 92.63% decline year-over-year.
- ProQR Therapeutics N.V. profit loss attributable to noncontrolling interests for the quarter ending 2023-03-31 was 78.00K EUR.
| Period end | Profit Loss Attributable To Noncontrolling Interests 3 month | Profit Loss Attributable To Noncontrolling Interests 6 month | Profit Loss Attributable To Noncontrolling Interests 9 month | Profit Loss Attributable To Noncontrolling Interests 12 month |
|---|---|---|---|---|
| 2023-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 290.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | 306.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | 384.00K EUR 20-F · filed 2026-03-12 |
| 2023-09-30 | 290.00K EUR 6-K · filed 2024-11-07 | 306.00K EUR derived: sum of 2 quarters · filed 2024-11-07 | 384.00K EUR 6-K · filed 2024-11-07 | 381.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | 16.00K EUR 6-K · filed 2024-08-08 | 94.00K EUR 6-K · filed 2024-08-08 | 91.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | 105.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | 78.00K EUR 6-K · filed 2024-05-09 | 75.00K EUR derived: sum of 2 quarters · filed 2025-03-13 | 89.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | 306.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | -3.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | 11.00K EUR derived: sum of 2 quarters · filed 2025-03-13 | 228.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | 220.00K EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | 14.00K EUR 6-K · filed 2023-11-07 | 231.00K EUR derived: sum of 2 quarters · filed 2023-11-07 | 223.00K EUR 6-K · filed 2023-11-07 | 204.00K EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 217.00K EUR 6-K · filed 2023-08-03 | 209.00K EUR 6-K · filed 2023-08-03 | 190.00K EUR derived: sum of 3 quarters · filed 2023-08-03 | 168.00K EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -8.00K EUR 6-K · filed 2023-05-16 | -27.00K EUR derived: sum of 2 quarters · filed 2023-05-16 | -49.00K EUR derived: sum of 3 quarters · filed 2023-05-16 | -56.00K EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | -19.00K EUR 6-K · filed 2022-02-24 | -41.00K EUR derived: sum of 2 quarters · filed 2022-11-09 | -48.00K EUR derived: sum of 3 quarters · filed 2022-11-09 | -59.00K EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | -22.00K EUR 6-K · filed 2022-11-09 | -29.00K EUR derived: sum of 2 quarters · filed 2022-11-09 | -40.00K EUR 6-K · filed 2022-11-09 | -51.00K EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -7.00K EUR 6-K · filed 2022-08-04 | -18.00K EUR 6-K · filed 2022-08-04 | -29.00K EUR derived: sum of 3 quarters · filed 2022-08-04 | -37.00K EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -11.00K EUR 6-K · filed 2022-05-05 | -22.00K EUR derived: sum of 2 quarters · filed 2022-05-05 | -30.00K EUR derived: sum of 3 quarters · filed 2022-05-05 | -37.00K EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -11.00K EUR 6-K · filed 2022-02-24 | -19.00K EUR derived: sum of 2 quarters · filed 2022-02-24 | -26.00K EUR derived: sum of 3 quarters · filed 2022-02-24 | -49.00K EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | -8.00K EUR 6-K · filed 2021-11-04 | -15.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | -38.00K EUR 6-K · filed 2021-11-04 | -83.00K EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -7.00K EUR 6-K · filed 2021-08-05 | -30.00K EUR 6-K · filed 2021-08-05 | -75.00K EUR derived: sum of 3 quarters · filed 2021-08-05 | -127.00K EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -23.00K EUR 6-K · filed 2020-05-07 | -68.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | -120.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | -202.00K EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | -45.00K EUR 6-K · filed 2021-02-25 | -97.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | -179.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | -266.00K EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | -52.00K EUR 6-K · filed 2020-11-16 | -134.00K EUR derived: sum of 2 quarters · filed 2020-11-16 | -222.00K EUR 6-K · filed 2020-11-16 | -278.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | -82.00K EUR 6-K · filed 2020-08-06 | -169.00K EUR 6-K · filed 2020-08-06 | -226.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -259.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | -87.00K EUR 6-K · filed 2020-05-07 | -144.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | -177.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -235.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | -57.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | -90.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | -148.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -192.00K EUR 20-F · filed 2021-03-24 |
| 2018-09-30 | -33.00K EUR 6-K · filed 2019-11-12 | -91.00K EUR derived: sum of 2 quarters · filed 2019-11-12 | -135.00K EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | -58.00K EUR 6-K · filed 2019-08-07 | -102.00K EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | -38.00K EUR 20-F · filed 2020-03-31 |